Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for SHR-2004 Injection aimed at preventing postoperative venous thromboembolism in patients undergoing ovarian cancer surgery; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Venous Thromboembolism

Drugs mentioned

• SHR-2004 Injection (SHR-2004)

Snippet

Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd | Conditions: Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery | Phase 2 | Status: COMPLETED